Moreover, because MSI is closely related to CRC and MSI-high status is an emerging predictive and prognostic biomarker for the immunotherapy response in cancer [21], we measured the associations of MUC4 polymorphisms with MSI status (Table 3). Here, MUC4 is linked to cancer.